Jasper Therapeutics, Inc. (NASDAQ:JSPR) Given Consensus Recommendation of “Buy” by Analysts
Shares of Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) have received a consensus rating of “Buy” from the ten research firms that are presently covering the firm, Marketbeat reports. Ten investment analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have updated their coverage on […]
More Stories
Bath Savings Trust Co Lowers Stock Position in Pool Co. (NASDAQ:POOL)
Bath Savings Trust Co decreased its position in Pool Co. (NASDAQ:POOL – Free Report) by 23.8% in the fourth quarter,...
Bath Savings Trust Co Lowers Holdings in Adobe Inc. (NASDAQ:ADBE)
Bath Savings Trust Co decreased its stake in Adobe Inc. (NASDAQ:ADBE – Free Report) by 9.0% during the fourth quarter,...
Janus Henderson Short Duration Income ETF (NYSEARCA:VNLA) is Rise Advisors LLC’s 5th Largest Position
Rise Advisors LLC lessened its holdings in Janus Henderson Short Duration Income ETF (NYSEARCA:VNLA – Free Report) by 13.5% during...
Rise Advisors LLC Trims Stake in Alliant Energy Co. (NASDAQ:LNT)
Rise Advisors LLC cut its stake in Alliant Energy Co. (NASDAQ:LNT – Free Report) by 4.6% in the fourth quarter,...
Rise Advisors LLC Has $150,000 Holdings in Target Co. (NYSE:TGT)
Rise Advisors LLC decreased its holdings in Target Co. (NYSE:TGT – Free Report) by 9.7% during the fourth quarter, according...
Rise Advisors LLC Sells 109 Shares of Prologis, Inc. (NYSE:PLD)
Rise Advisors LLC decreased its position in shares of Prologis, Inc. (NYSE:PLD – Free Report) by 18.0% during the fourth...